ENANTA PHARMACEUTICALS, INC Capital Leases, Future Minimum Payments, Remainder of Fiscal Year
ENANTA PHARMACEUTICALS, INC (ENTA) had Capital Leases, Future Minimum Payments, Remainder of Fiscal Year of $93.00 thousand as of 2019-09-30, per its 10-Q filed 2020-08-10.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-08-10
- 2019-09-30: Capital Leases, Future Minimum Payments, Remainder of Fiscal Year $93.00K.
| Period end | Capital Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2019-09-30 | $93.00K 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |